vladimirsorokin / iStockphoto.com
Watson Laboratories (a subsidiary of Teva) has secured a win at the US Court of Appeals for the Federal Circuit, after the court said Watson did prove that Bayer’s patent claims were obvious.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bayer, Watson Laboratories, patent, patent infringement, US Court of Appeals for the Federal Circuit, erectile dysfunction